Application of topical gentamicin ointment in the treatment of Nagashima‐type palmoplantar keratosis in children with a nonsense mutation
Pediatric Investigation · 2023-09 · 7 (3) · 163-167
DOI: 10.1002/ped4.12389 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Investigation, online erschienen am 28.06.2023. Verfasst von Shan Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Beijing Children's Hospital Capital Medical University, National Center for Children's Health Beijing China. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Importance Nagashima‐type palmoplantar keratosis (NPPK) is a hereditary dermatosis mostly caused by a nonsense mutation in SERPINB7 . Despite the increasing interest in readthrough gentamicin treatment of NPPK, clinical evidence for this treatment is limited.
Objective
This study aimed to provide further evidence for the use of topical gentamicin in the treatment of NPPK in children with nonsense mutations.
Methods
We designed a bilaterally controlled study of topical gentamicin ointment. Children diagnosed with NPPK carrying nonsense mutations were enrolled in this study. A 0.1% gentamicin ointment was applied to one hand and an emollient to the other for 3 months. A bilateral comparison of the visual analog scale scores for clinical manifestations and safety was performed.
Results
Ten children with NPPK were included in this study. In comparison with the emollient side, the topical gentamicin side showed significant improvements in hyperkeratosis, erythema, maceration, and desquamation after 1 and 3 months of treatment ( P < 0.05). However, hyperhidrosis and odor did not improve significantly. No adverse events were observed during the systemic safety monitoring examinations.
Interpretation
Topical gentamicin ointment showed good safety in the treatment of NPPK with nonsense mutations, indicating that it is a promising therapeutic choice in children with NPPK.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Beijing Children's Hospital Capital Medical University, National Center for Children's Health Beijing China.
- Department of Pharmacy, Beijing Children's Hospital Capital Medical University, National Center for Children's Health Beijing China.
- Department of Otolaryngology, Head and Neck Surgery Beijing Key Laboratory for Pediatric Diseases of Otolaryngology, Head and Neck Surgery Beijing Children's Hospital, Capital Medical University, National Center for Chi…
- Department of Respiratory Medicine China National Clinical Research Center for Respiratory Diseases Beijing Children's Hospital, Capital Medical University, National Center for Children's Health Beijing China.
Zitieren
APA
Wang, S., Yang, Z., Liu, Y., Zhang, H., Liu, Z., Wang, X., Li, Y., Liu, H., Yang, Y., & Ma, L. (2023). Application of topical gentamicin ointment in the treatment of Nagashima‐type palmoplantar keratosis in children with a nonsense mutation. Pediatric Investigation, 7(3), 163-167. https://doi.org/10.1002/ped4.12389
Vancouver
Wang S, Yang Z, Liu Y, Zhang H, Liu Z, Wang X, et al. Application of topical gentamicin ointment in the treatment of Nagashima‐type palmoplantar keratosis in children with a nonsense mutation. Pediatric Investigation. 2023;7(3):163-167. doi:10.1002/ped4.12389
BibTeX
@article{Wang2023,
author = {Wang, Shan and Yang, Zhou and Liu, Ying and Zhang, Huan and Liu, Zongyang and Wang, Xiaoling and Li, Ying and Liu, Haihong and Yang, Yonghong and Ma, Lin},
title = {Application of topical gentamicin ointment in the treatment of Nagashima‐type palmoplantar keratosis in children with a nonsense mutation},
journal = {Pediatric Investigation},
year = {2023},
volume = {7},
number = {3},
pages = {163--167},
doi = {10.1002/ped4.12389}
}
EUVIMED